Skip to main content
. 2016 May 23;2016(5):CD007126. doi: 10.1002/14651858.CD007126.pub3

2. Publication bias risk assessment: safety outcomes.

Comparison/outcome Number of studies Number of participants n with outcome/total % with outcome Risk difference NNH Susceptibility to publication bias
      Active Control Active Control      
Comparison 11. Number of participants with adverse events
1 Paracetamol or propacetamol vs placebo 20 2359 557/1278 400/1081 44 37 0.04 (0.01 to 0.08) 25 NNH > 10
1.2 Propacetamol vs placebo 10 1409 278/740 197/669 38 29 0.05 (0.01 to 0.10) 20 NNH > 10
Comparison 14. Number of participants withdrawing due to lack of efficacy
1.2 Propacetamol vs placebo 14 889 25/477 47/412 5 11 ‐0.05 (‐0.08 to ‐0.02) 20* NNH > 10
Comparison 15. Number of participants with pain on infusion
2. Propacetamol vs placebo 6 645 75/333 4/312 23 1 0.20 (0.16 to 0.24) 5 645
3. Propacetamol vs paracetamol 3 362 71/182 8/180 39 4 0.35 (0.27 to 0.42) 3 904
Comparison 16. Individual adverse events: paracetamol or propacetamol vs placebo
1. Nausea: Paracetamol or propacetamol vs placebo 15 1267 189/660 213/607 29 35 ‐0.05 (‐0.10 to ‐0.01) 20* NNH > 10
1.1. Nausea: Paracetamol vs placebo 13 1037 153/520 196/517 29 38 ‐0.09 (‐0.14 to ‐0.04) 11* NNH > 10
2. Vomiting: Paracetamol or propacetamol vs placebo 15 1414 103/721 144/693 14 21 ‐0.06 (‐0.10 to ‐0.03) 17* NNH > 10
2.1. Vomiting: Paracetamol vs placebo 13 1037 88/520 136/517 17 26 ‐0.10 (‐0.14 to ‐0.05) 10* NNH > 10
Comparison 18. Individual adverse events: paracetamol or propacetamol vs opioids
1. Nausea: Paracetamol or propacetamol vs opioids 6 545 19/272 48/273 7 18 ‐0.11 (‐0.16 to ‐0.05) 10* 55
1.1 Nausea: Paracetamol vs opioids 4 438 12/219 39/219 5 18 ‐0.12 (‐0.18 to ‐0.07) 9* 88
2. Vomiting: Paracetamol or propacetamol vs opioids 5 495 6/247 20/248 2 8 ‐0.06 (‐0.09 to ‐0.02) 17* NNH > 10
2.1. Vomiting: Paracetamol vs opioids 3 388 4/194 16/194 2 8 ‐0.06 (‐0.10 to ‐0.02) 17* NNH > 10
6.1. Sedation: Paracetamol vs opioids 3 354 2/176 26/178 1 15 ‐0.14 (‐0.18 to ‐0.09) 8* 142

*lower occurrence of adverse event in paracetamol and/or propacetamol arm